• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation.线粒体活性氧介导溶血磷脂酰胆碱诱导的内皮细胞活化。
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1090-100. doi: 10.1161/ATVBAHA.115.306964. Epub 2016 Apr 28.
2
IL-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3K14 (Histone 3 Lysine 14).白细胞介素 35(IL-35)通过抑制线粒体活性氧物质介导的 H3K14(组蛋白 3 赖氨酸 14)特异性位点乙酰化抑制内皮细胞激活。
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):599-609. doi: 10.1161/ATVBAHA.117.310626. Epub 2018 Jan 25.
3
Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway.早期高脂血症通过半胱天冬酶-1-沉默调节蛋白1途径促进内皮细胞活化。
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):804-16. doi: 10.1161/ATVBAHA.115.305282. Epub 2015 Feb 19.
4
Role of Hic-5 in the formation of microvilli-like structures and the monocyte-endothelial interaction that accelerates atherosclerosis.Hic-5 在微绒毛样结构形成和加速动脉粥样硬化的单核细胞-内皮细胞相互作用中的作用。
Cardiovasc Res. 2015 Mar 1;105(3):361-71. doi: 10.1093/cvr/cvv003. Epub 2015 Jan 12.
5
Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-alpha and subsequent activation of the p21Cip1/Ets-1/p300 system.动脉粥样硬化早期的炎症反应是由富含脯氨酸的酪氨酸激酶/活性氧物质介导的肿瘤坏死因子-α的释放,以及随后的 p21Cip1/Ets-1/p300 系统的激活所诱导的。
Arterioscler Thromb Vasc Biol. 2011 May;31(5):1084-92. doi: 10.1161/ATVBAHA.110.221804. Epub 2011 Mar 3.
6
Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells.抗炎细胞因子 IL-35 和 IL-10 阻断动脉粥样硬化性溶血磷脂酰胆碱诱导的、线粒体 ROS 介导的固有免疫激活,但在血管内皮细胞中保留固有免疫记忆特征。
Redox Biol. 2020 Jan;28:101373. doi: 10.1016/j.redox.2019.101373. Epub 2019 Nov 6.
7
Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.血清淀粉样蛋白A通过晚期糖基化终末产物受体的信号传导作为尿毒症相关动脉粥样硬化的一种可能机制。
Arterioscler Thromb Vasc Biol. 2016 May;36(5):800-9. doi: 10.1161/ATVBAHA.115.306349. Epub 2016 Mar 17.
8
Vascular effects of oxysterols and oxyphytosterols in apoE -/- mice.载脂蛋白 E 基因敲除小鼠中氧化固醇和氧化植物固醇的血管作用。
Atherosclerosis. 2015 May;240(1):73-9. doi: 10.1016/j.atherosclerosis.2015.02.032. Epub 2015 Feb 26.
9
Lysophosphatidylcholine induces oxidative stress in human endothelial cells via NOX5 activation - implications in atherosclerosis.溶血磷脂酰胆碱通过激活 NOX5 诱导人内皮细胞氧化应激 - 在动脉粥样硬化中的意义。
Clin Sci (Lond). 2021 Aug 13;135(15):1845-1858. doi: 10.1042/CS20210468.
10
P-Selectin Expressed by a Human SELP Transgene Is Atherogenic in Apolipoprotein E-Deficient Mice.人类SELP转基因表达的P-选择素在载脂蛋白E缺陷小鼠中具有致动脉粥样硬化作用。
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1114-21. doi: 10.1161/ATVBAHA.116.307437. Epub 2016 Apr 21.

引用本文的文献

1
Metabolic Disturbances Involved in Cardiovascular Diseases: The Role of Mitochondrial Dysfunction, Altered Bioenergetics and Oxidative Stress.心血管疾病中的代谢紊乱:线粒体功能障碍、生物能量改变及氧化应激的作用
Int J Mol Sci. 2025 Jul 15;26(14):6791. doi: 10.3390/ijms26146791.
2
Alzheimer's disease as an auto-innate immune pathology with potential cell trans-differentiation and enhanced trained immunity in 3xTg-AD mouse model.在3xTg-AD小鼠模型中,阿尔茨海默病作为一种具有潜在细胞转分化和增强训练免疫的自身固有免疫病理学。
J Alzheimers Dis. 2025 May;105(2):550-572. doi: 10.1177/13872877251329583. Epub 2025 Apr 15.
3
The Dual Role of Oxidative Stress in Atherosclerosis and Coronary Artery Disease: Pathological Mechanisms and Diagnostic Potential.氧化应激在动脉粥样硬化和冠状动脉疾病中的双重作用:病理机制与诊断潜力
Antioxidants (Basel). 2025 Feb 26;14(3):275. doi: 10.3390/antiox14030275.
4
Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake.内皮细胞中的线粒体钙摄取蛋白1通过抑制线粒体钙摄取来预防血管炎症和动脉粥样硬化。
J Clin Invest. 2025 Apr 1;135(7):e181928. doi: 10.1172/JCI181928.
5
Lipidomic insights on abdominal aortic aneurysm and peripheral arterial disease.腹主动脉瘤和外周动脉疾病的脂质组学见解
J Mol Med (Berl). 2025 Apr;103(4):365-380. doi: 10.1007/s00109-025-02524-1. Epub 2025 Feb 26.
6
Systematic Review of Interleukin-35 in Endothelial Dysfunction: A New Target for Therapeutic Intervention.内皮功能障碍中白细胞介素-35的系统评价:治疗干预的新靶点
Mediators Inflamm. 2025 Feb 12;2025:2003124. doi: 10.1155/mi/2003124. eCollection 2025.
7
Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4Foxp3 Regulatory T Cell Immunosuppression.免疫检查点是调节心脑血管疾病和CD4Foxp3调节性T细胞免疫抑制的新治疗靶点。
Int J Drug Discov Pharm. 2024 Dec;3(4). doi: 10.53941/ijddp.2024.100022. Epub 2024 Nov 26.
8
The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.血脑屏障在神经退行性疾病中的关键作用:破坏机制及治疗意义
J Clin Med. 2025 Jan 9;14(2):386. doi: 10.3390/jcm14020386.
9
Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasion.线粒体呼吸复合物III维持活化巨噬细胞中白细胞介素-10的产生并促进肿瘤介导的免疫逃逸。
Sci Adv. 2025 Jan 24;11(4):eadq7307. doi: 10.1126/sciadv.adq7307. Epub 2025 Jan 22.
10
Impaired endothelial function contributes to cardiac dysfunction: role of mitochondrial dynamics.内皮功能受损导致心脏功能障碍:线粒体动力学的作用。
Am J Physiol Heart Circ Physiol. 2025 Jan 1;328(1):H29-H36. doi: 10.1152/ajpheart.00531.2024. Epub 2024 Nov 19.

本文引用的文献

1
Lysophospholipids and their G protein-coupled receptors in atherosclerosis.动脉粥样硬化中的溶血磷脂及其G蛋白偶联受体
Front Biosci (Landmark Ed). 2016 Jan 1;21(1):70-88. doi: 10.2741/4377.
2
Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy.缺血性卒中中的内皮祖细胞:从假说到治疗的探索
J Hematol Oncol. 2015 Apr 11;8:33. doi: 10.1186/s13045-015-0130-8.
3
Mitochondria in the regulation of innate and adaptive immunity.线粒体在先天性免疫和适应性免疫调节中的作用
Immunity. 2015 Mar 17;42(3):406-17. doi: 10.1016/j.immuni.2015.02.002.
4
Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway.早期高脂血症通过半胱天冬酶-1-沉默调节蛋白1途径促进内皮细胞活化。
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):804-16. doi: 10.1161/ATVBAHA.115.305282. Epub 2015 Feb 19.
5
Anti-inflammatory therapies for atherosclerosis.抗动脉粥样硬化炎症治疗。
Nat Rev Cardiol. 2015 Apr;12(4):199-211. doi: 10.1038/nrcardio.2015.5. Epub 2015 Feb 10.
6
Heart disease and stroke statistics--2015 update: a report from the American Heart Association.《2015年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2015 Jan 27;131(4):e29-322. doi: 10.1161/CIR.0000000000000152. Epub 2014 Dec 17.
7
Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function.免疫抑制/抗炎细胞因子直接或间接抑制内皮功能障碍——维持血管功能的新机制。
J Hematol Oncol. 2014 Oct 31;7:80. doi: 10.1186/s13045-014-0080-6.
8
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.急性冠脉综合征后达拉帕利德对主要冠脉事件的影响:SOLID-TIMI 52 随机临床试验。
JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061.
9
Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis.高同型半胱氨酸血症增强高血糖诱导的炎症单核细胞分化和动脉粥样硬化。
Diabetes. 2014 Dec;63(12):4275-90. doi: 10.2337/db14-0809. Epub 2014 Jul 9.
10
Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid.Mfsd2a 是一种必需的ω-3 脂肪酸二十二碳六烯酸的转运蛋白。
Nature. 2014 May 22;509(7501):503-6. doi: 10.1038/nature13241. Epub 2014 May 14.

线粒体活性氧介导溶血磷脂酰胆碱诱导的内皮细胞活化。

Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation.

作者信息

Li Xinyuan, Fang Pu, Li Yafeng, Kuo Yin-Ming, Andrews Andrew J, Nanayakkara Gayani, Johnson Candice, Fu Hangfei, Shan Huimin, Du Fuyong, Hoffman Nicholas E, Yu Daohai, Eguchi Satoru, Madesh Muniswamy, Koch Walter J, Sun Jianxin, Jiang Xiaohua, Wang Hong, Yang Xiaofeng

机构信息

From the Centers for Metabolic Disease Research, Cardiovascular Research, Thrombosis Research (X.L., P.F., Y.L., G.N., C.J., H.F., H.S., F.D., S.E., X.J., H.W., X.Y.), Department of Pharmacology (X.L., P.F., Y.L., G.N., C.J., H.F., H.S., F.D., W.J.K., X.J., H.W., X.Y.), Department of Biochemistry (N.E.H., M.M.), Department of Physiology (S.E.), Center for Translational Medicine (N.E.H., M.M., W.J.K.), and Department of Clinical Sciences (D.Y.), Temple University School of Medicine, Philadelphia, PA; Department of Cancer Biology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA (Y.-M.K., A.J.A.); and Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA (J.S.).

出版信息

Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1090-100. doi: 10.1161/ATVBAHA.115.306964. Epub 2016 Apr 28.

DOI:10.1161/ATVBAHA.115.306964
PMID:27127201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4882253/
Abstract

OBJECTIVE

Hyperlipidemia-induced endothelial cell (EC) activation is considered as an initial event responsible for monocyte recruitment in atherogenesis. However, it remains poorly defined what is the mechanism underlying hyperlipidemia-induced EC activation. Here, we tested a novel hypothesis that mitochondrial reactive oxygen species (mtROS) serve as signaling mediators for EC activation in early atherosclerosis.

APPROACH AND RESULTS

Metabolomics and transcriptomics analyses revealed that several lysophosphatidylcholine (LPC) species, such as 16:0, 18:0, and 18:1, and their processing enzymes, including Pla2g7 and Pla2g4c, were significantly induced in the aortas of apolipoprotein E knockout mice during early atherosclerosis. Using electron spin resonance and flow cytometry, we found that LPC 16:0, 18:0, and 18:1 induced mtROS in primary human aortic ECs, independently of the activities of nicotinamide adenine dinucleotide phosphate oxidase. Mechanistically, using confocal microscopy and Seahorse XF mitochondrial analyzer, we showed that LPC induced mtROS via unique calcium entry-mediated increase of proton leak and mitochondrial O2 reduction. In addition, we found that mtROS contributed to LPC-induced EC activation by regulating nuclear binding of activator protein-1 and inducing intercellular adhesion molecule-1 gene expression in vitro. Furthermore, we showed that mtROS inhibitor MitoTEMPO suppressed EC activation and aortic monocyte recruitment in apolipoprotein E knockout mice using intravital microscopy and flow cytometry methods.

CONCLUSIONS

ATP synthesis-uncoupled, but proton leak-coupled, mtROS increase mediates LPC-induced EC activation during early atherosclerosis. These results indicate that mitochondrial antioxidants are promising therapies for vascular inflammation and cardiovascular diseases.

摘要

目的

高脂血症诱导的内皮细胞(EC)激活被认为是动脉粥样硬化发生过程中单核细胞募集的起始事件。然而,高脂血症诱导EC激活的潜在机制仍不清楚。在此,我们验证了一个新的假说,即线粒体活性氧(mtROS)作为早期动脉粥样硬化中EC激活的信号介质。

方法与结果

代谢组学和转录组学分析显示,在早期动脉粥样硬化期间,载脂蛋白E基因敲除小鼠的主动脉中,几种溶血磷脂酰胆碱(LPC)种类,如16:0、18:0和18:1,以及它们的加工酶,包括Pla2g7和Pla2g4c,均显著上调。通过电子自旋共振和流式细胞术,我们发现LPC 16:0、18:0和18:1在原代人主动脉EC中诱导mtROS产生,且不依赖于烟酰胺腺嘌呤二核苷酸磷酸氧化酶的活性。机制上,利用共聚焦显微镜和海马XF线粒体分析仪,我们发现LPC通过独特的钙内流介导的质子泄漏增加和线粒体氧还原诱导mtROS产生。此外,我们发现mtROS通过调节激活蛋白-1的核结合并在体外诱导细胞间黏附分子-1基因表达,从而促进LPC诱导的EC激活。此外,我们利用活体显微镜和流式细胞术方法表明,mtROS抑制剂MitoTEMPO可抑制载脂蛋白E基因敲除小鼠的EC激活和主动脉单核细胞募集。

结论

ATP合成解偶联但质子泄漏偶联的mtROS增加介导了早期动脉粥样硬化中LPC诱导的EC激活。这些结果表明,线粒体抗氧化剂有望用于治疗血管炎症和心血管疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/54a974fae589/nihms-779832-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/54f85b7f9012/nihms-779832-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/41ef647a8d00/nihms-779832-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/9cbb0d406705/nihms-779832-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/2fd2f30ba8db/nihms-779832-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/57ea00abbda6/nihms-779832-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/e5028e6535be/nihms-779832-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/0edcb4807903/nihms-779832-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/54a974fae589/nihms-779832-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/54f85b7f9012/nihms-779832-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/41ef647a8d00/nihms-779832-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/9cbb0d406705/nihms-779832-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/2fd2f30ba8db/nihms-779832-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/57ea00abbda6/nihms-779832-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/e5028e6535be/nihms-779832-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/0edcb4807903/nihms-779832-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b656/4882253/54a974fae589/nihms-779832-f0008.jpg